Bryon D. Johnson

机构：Medical College of Wisconsin, European Society for Blood and Marrow Transplantation · ORCID：0000-0001-7416-3396

发表论文 232 篇 · 总被引 4624 次 · h-index 35

代表论文

Phase I/II Study of Adaptive Manufactured Lentiviral Anti-CD20/Anti-CD19 Chimeric Antigen Receptor T Cells for Relapsed, Refractory Mantle Cell Lymphoma (2025 · Journal of Clinical Oncology · 被引 14)
Platelet-Targeted Gene Therapy for Hemophilia A with Inhibitor History (2025 · New England Journal of Medicine · 被引 14)
Phase 1 Study of Trispecific Anti-CD20, Anti-CD19, Anti-CD22 (CAR20.19.22) T Cells for Relapsed, Refractory B-Cell Malignancies (2024 · Blood · 被引 7)
Correction: Randomized Phase II Trial of Dendritic Cell/Myeloma Fusion Vaccine with Lenalidomide Maintenance after Upfront Autologous Hematopoietic Cell Transplantation for Multiple Myeloma: BMT CTN 1401 (2024 · Clinical Cancer Research · 被引 2)
Combination of pirtobrutinib and lentiviral transduced bispecific anti-CD20/CD19 (LV20.19) CAR T-cell therapy to improve outcomes in patients with relapsed/refractory lymphoma. (2024 · Journal of Clinical Oncology · 被引 2)
Phase 1 Trial of LV20.19 CAR T-Cells for Relapsed, Refractory CLL and Richter's Transformation (2024 · Transplantation and Cellular Therapy · 被引 2)